HbA1c and Blood-Sugar Targets, Made Simple?

If you have type 2 diabetes you'll hear a lot about HbA1c. Here's what it means and where GLP-1s fit.

Key takeaways

• HbA1c reflects your average blood sugar over roughly three months.
• Staying near your target lowers long-term risks.
• Targets are personal — set with your team.
• GLP-1s can help bring HbA1c down, often gently.

One number tends to dominate type 2 diabetes conversations: HbA1c. It sounds technical, but the idea behind it is genuinely simple — and once it clicks, a lot of the advice you've been given starts to make sense.

If you have type 2 diabetes, you'll have seen this figure on letters from the surgery, heard it mentioned at review appointments, and perhaps watched a nurse note it down with a nod. It's worth understanding, because it's the main yardstick the NHS uses to see how your diabetes is tracking over time — not just on the day of a test, but across the months between.

What it actually measures

HbA1c reflects your average blood sugar over roughly three months, by measuring how much sugar has attached itself to the haemoglobin in your red blood cells. Because those cells live for about that long, the test captures a rolling picture rather than a single moment.

Think of it as the difference between a single photograph and a time-lapse. A finger-prick reading tells you where your blood sugar sits right now — useful, but easily nudged by a recent meal, a stressful morning or a poor night's sleep. HbA1c quietly averages all of that out, which is why your team leans on it for the bigger picture.

Why it matters for the long run

Keeping HbA1c within a sensible range lowers the long-term risks that come with blood sugar running high for years — the slow effects it can have on the eyes, kidneys, nerves, heart and circulation. The goal isn't a flawless number on a single day; it's a steadier average over the months and years.

Your target is personal

There isn't one universal figure everyone should hit. A sensible target depends on your age, how long you've had diabetes, which other medicines you take, and your wider health — so it's set together with your GP, practice nurse or diabetes team rather than copied from a leaflet.

For some people a gentler target is the safer, kinder choice — pushing too hard can bring its own problems, especially with treatments that can cause low blood sugar. That's why it's a conversation rather than a one-size-fits-all rule, and why two people with similar readings can be given quite different goals.

Where GLP-1 medicines come in

GLP-1 medicines can help bring HbA1c down by prompting your body to release its own insulin when blood sugar rises after a meal, and by steadying those post-meal peaks. Because they tend to act mainly when sugar is high, they often lower the average without the lows that some other treatments can cause on their own.

If you also take insulin or a sulfonylurea, your prescriber may keep a closer eye on things when a GLP-1 is added, since the combination can change your risk of a hypo. There's more on this in How GLP-1s Fit With Other Type 2 Diabetes Treatments.

What this means for you

You don't need to memorise the science. The useful takeaway is this: HbA1c is a slow-moving average, so changes take a few months to show up. If your number drifts down bit by bit, that's exactly how it's meant to work — there's no need to expect a dramatic shift between one appointment and the next, and no reason to feel discouraged if progress is gradual.

Progress beats perfection A small, steady improvement is meaningful — it adds up over years. It's worth celebrating progress rather than chasing a flawless figure, and bringing any questions about your own target to your next review.

Sources

• NICE
• NHS
• World Health Organization (WHO)